Old Web
English
Sign In
Acemap
>
authorDetail
>
Vijay Kt Alagappan
Vijay Kt Alagappan
Novartis
COPD
Medicine
Indacaterol
Bronchodilator
Tolerability
3
Papers
327
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Use of a 4-week up-titration regimen of roflumilast in patients with severe COPD
2018
International Journal of Chronic Obstructive Pulmonary Disease
Henrik Watz
Nitin Bagul
Klaus F. Rabe
Stephen I. Rennard
Vijay Kt Alagappan
Jonas Román
Axel Facius
Peter Calverley
Show All
Source
Cite
Save
Citations (18)
Efficacy and safety of QVA149 compared to the concurrent administration of its monocomponents indacaterol and glycopyrronium: the BEACON study.
2013
International Journal of Chronic Obstructive Pulmonary Disease
Ronald Dahl
Dalal Jadayel
Vijay Kt Alagappan
Hungta Chen
Donald Banerji
Show All
Source
Cite
Save
Citations (57)
Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol–fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study
2013
The Lancet Respiratory Medicine
Claus Vogelmeier
Eric D. Bateman
John Pallante
Vijay Kt Alagappan
Peter D’Andrea
Hungta Chen
Donald Banerji
Show All
Source
Cite
Save
Citations (252)
1